The engineered T cells kill CD19+ cells via STAR receptor–redirected TCR–CD3 signaling. HLA-A is not a recognized target for killing (it is knocked out on the infused T cells to reduce alloreactivity), so HLA-A–expressing cells are not directly killed unless they also express CD19, in which case killing is driven by CD19, not HLA-A.